Genscript Biotech Corporation (1548.HK)

HKD 11.18

(2.38%)

EBITDA Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual EBITDA in 2023 was -249.42 Million USD , up 28.32% from previous year.
Genscript Biotech Corporation's latest quarterly EBITDA in 2024 Q2 was -117.93 Million USD , up 28.21% from previous quarter.
Genscript Biotech Corporation reported an annual EBITDA of -389.03 Million USD in 2022, down -13.9% from previous year.
Genscript Biotech Corporation reported an annual EBITDA of -341.56 Million USD in 2021, down -95.51% from previous year.
Genscript Biotech Corporation reported a quarterly EBITDA of -194.23 Million USD for 2023 Q2, up 17.74% from previous quarter.
Genscript Biotech Corporation reported a quarterly EBITDA of -164.28 Million USD for 2023 Q4, up 15.42% from previous quarter.

Annual EBITDA Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual EBITDA of Genscript Biotech Corporation (2023 - 2013)

Year	EBITDA	EBITDA Growth
2023	-249.42 Million USD	28.32%
2022	-389.03 Million USD	-13.9%
2021	-341.56 Million USD	-95.51%
2020	-174.7 Million USD	-55.49%
2019	-112.36 Million USD	-744.13%
2018	17.44 Million USD	-62.25%
2017	46.2 Million USD	54.14%
2016	29.97 Million USD	92.32%
2015	15.58 Million USD	31.89%
2014	11.81 Million USD	-9.68%
2013	13.08 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-117.93 Million USD	28.21%
2023 Q2	-194.23 Million USD	17.74%
2023 Q4	-164.28 Million USD	15.42%
2023 FY	- USD	28.32%
2022 FY	- USD	-13.9%
2022 Q4	-236.13 Million USD	-54.57%
2022 Q2	-152.76 Million USD	27.06%
2021 FY	- USD	-95.51%
2021 Q4	-209.45 Million USD	-58.54%
2021 Q2	-132.11 Million USD	-28.71%
2020 Q2	-72.06 Million USD	9.47%
2020 FY	- USD	-55.49%
2020 Q4	-102.64 Million USD	-42.44%
2019 FY	- USD	-744.13%
2019 Q4	-79.59 Million USD	-142.94%
2019 Q2	-32.76 Million USD	-820.34%
2018 Q4	-3.56 Million USD	-116.95%
2018 Q2	21 Million USD	-14.82%
2018 FY	- USD	-62.25%
2017 Q4	24.65 Million USD	14.43%
2017 FY	- USD	54.14%
2017 Q2	21.54 Million USD	63.23%
2016 Q2	16.77 Million USD	182.36%
2016 Q4	13.2 Million USD	-21.31%
2016 FY	- USD	92.32%
2015 Q4	5.94 Million USD	-38.4%
2015 Q2	9.64 Million USD	81.71%
2015 FY	- USD	31.89%
2014 Q4	5.3 Million USD	-18.45%
2014 Q2	6.5 Million USD	98.02%
2014 FY	- USD	-9.68%
2013 Q4	3.28 Million USD	0.0%
2013 FY	- USD	0.0%

Peer EBITDA Comparison of Genscript Biotech Corporation

Name	EBITDA	EBITDA Difference
Uni-Bio Science Group Limited	91.23 Million HKD	373.388%
CK Life Sciences Int'l., (Holdings) Inc.	486.79 Million HKD	151.238%